Involvement of Ca2+, CaMK II and PKA in EGb 761-induced insulin secretion in INS-1 cells
Involvement of Ca2+, CaMK II and PKA in EGb 761-induced insulin secretion in INS-1 cells
复制标题
DOI:
10.1016/j.jep.2006.09.001
复制
发表时间:
2007-03-01
影响因子:
5.4
通讯作者:
Kang, Yup
中科院分区:
文献类型:
--
作者:
Choi, Sung-E.;Shin, Ha-Chul;Kang, Yup
EGb 761, a standardized form of Ginkgo biloba L. (Ginkgoaceae) leaf extract, was recently reported to increase pancreatic beta-cell function. To determine whether EGb 761 elicits insulin secretion directly, we treated INS-1 rat beta cells with EGb 761 and then measured insulin release. Treatment of EGb 761 (50 mu g/ml) significantly stimulated insulin secretion in INS-1 cells, compared with untreated control (P < 0.05) and the stimulatory effect of EGb 761 on insulin secretion was dose-dependent. To elucidate the mechanism of EGb 761-induced insulin secretion, we investigated the involvement of calcium. The treatment with nifedipine, an L-type calcium channel blocker, prevented EGb 761-induced insulin secretion and furthermore, EGb 761 itself elevated [Ca2+](i), suggesting the involvement of calcium in this process. To identity the protein kinases involved in EGb 761-induced insulin secretion, INS-1 cells were treated with different kinase inhibitors and their effects on EGb 761-induced secretion were investigated. KN62 and H89, calium/calmodulin kinase (CaMK) II and protein kinase A (PKA) inhibitor, respectively, significantly reduced EGb 761-induced insulin secretion. Immumoblotting studies showed an increase in the phosphorylated-forms of CaMK II and of PKA substrates after EGb 761 treatment. Our data suggest that EGb 761-induced insulin secretion is mediated by [Ca2+](i) elevation and subsequent activation of CaMK H and PKA. (c) 2006 Published by Elsevier Ireland Ltd.